Clinical Trial Update: Nelfinavir, a Phase I/Phase II Rectal Cancer Study [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase I/II trial of nelfinavir for colorectal cancer (rectal cancer) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Colorectal Cancer, Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED